PTC Therapeutics | Spese Operative



Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amgen USD 6.78B 401M 2024-12
Biogen USD 2.01B 13.3M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Cytokinetics USD 155.97M 14.7M 2024-12
Daiichi Sankyo JPY 423.43B 70.8B 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
Incyte USD 877.18M 114.6M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 18.17B 5.63B 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Xencor USD 65.97M 7.02M 2024-12



PTC Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.